CNNMoney.com »

Market Tracker

09/29 5:16pm ET

Dow
-195.79
18,143.45
-1.07%
S&P 500
-20.24
2,151.13
-0.93%
Nasdaq
-49.40
5,269.15
-0.93%
Russell 2000
-17.91
1,237.75
-1.43%
FTSE 100
+111.75
6,919.42
+1.64%
DAX
+44.06
10,405.54
+0.43%

Merck & Co Inc (NYSE:MRK)

Add to Watch List

61.91

Delayed Data

As of 4:00pm ET

-1.39 / -2.20%

Today’s Change

47.97

Today|||52-Week Range

64.00

+17.21%

Year-to-Date

Latest MRK News | Press Releases

Deutsche Bank's Losses Affecting the Market on Thursday 6:05pm / GuruFocus News - Paid Partner Content	Takeover Chatter Around Clovis May Be Overdone Sep 23 / TheStreet.com - Paid Partner Content
Stocks Higher With OPEC Agreement 10:16am / GuruFocus News - Paid Partner Content	BioLineRx Begins Trial on BL-8040/ Keytruda Combination Sep 21 / Zacks.com - Paid Partner Content
Gilead Sciences Stock Downgraded: 3 Things You Need to Know Sep 28 / MotleyFool.com - Paid Partner Content	Opinions split on Witty regime at GSK Sep 20 / FT.com - Paid Partner Content
Investors Reward Merck Despite Flat Revenue Growth Sep 27 / GuruFocus News - Paid Partner Content	Theresa May Assures IBM, Amazon, Goldman Sachs About Brexit Sep 20 / Zacks.com - Paid Partner Content
Eli Lilly Stock Upgraded: What You Need to Know Sep 27 / MotleyFool.com - Paid Partner Content	Meet Big Pharma's new female CEO Sep 20 / CNNMoney.com
Amgen/UCB's BLA for Osteoporosis Drug Accepted in the U.S. Sep 27 / Zacks.com - Paid Partner Content	How Safe Is Gilead Sciences Inc. and Its Dividend? Sep 20 / MotleyFool.com - Paid Partner Content
Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy Sep 27 / TheStreet.com - Paid Partner Content	This Diabetes Breakthrough Is Great News or Terrible News, Depending on Your Perspect... Sep 19 / MotleyFool.com - Paid Partner Content
Wall Street Sells Off on Worries Over Clinton-Trump Showdown Sep 26 / TheStreet.com - Paid Partner Content	Merck/Pfizer Diabetes Drug Ertugliflozin Positive in Phase III Sep 16 / Zacks.com - Paid Partner Content
Stocks Fall Ahead of Clinton-Trump Debate, Crude Rallies Sep 26 / TheStreet.com - Paid Partner Content	Europeans are among those most sceptical of vaccine safety Sep 14 / FT.com - Paid Partner Content
Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014? Sep 26 / MotleyFool.com - Paid Partner Content	Bristol-Myers Squibb misses mark with cancer drug Aug 30 / FT.com - Paid Partner Content